All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Mechanisms of renal hyporesponsiveness to BNP in heart failure

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00062968" target="_blank" >RIV/00159816:_____/15:00062968 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1139/cjpp-2014-0356" target="_blank" >http://dx.doi.org/10.1139/cjpp-2014-0356</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1139/cjpp-2014-0356" target="_blank" >10.1139/cjpp-2014-0356</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Mechanisms of renal hyporesponsiveness to BNP in heart failure

  • Original language description

    The B-type natriuretic peptide (BNP), a member of the family of vasoactive peptides, is a potent natriuretic, diuretic, and vasodilatory peptide that contributes to blood pressure and volume homeostasis. These attributes make BNP an ideal drug that couldaid in diuresing a fluid-overloaded patient who had poor or worsening renal function. Despite the potential benefits of BNP, accumulating evidence suggests that simply increasing the amount of circulating BNP does not necessarily increase natriuresis inpatients with heart failure (HF). Moreover, despite high BNP levels, natriuresis falls when HF progresses from a compensated to a decompensated state, suggesting the emergence of renal resistance to BNP. Although likely multifactorial, several mechanisms have been proposed to explain renal hyporesponsiveness in HF, including, but not limited to, decreased renal BNP availability, down-regulation of natriuretic peptide receptors, and altered BNP intracellular signal transduction pathways.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Canadian Journal of Physiology and Pharmacology

  • ISSN

    0008-4212

  • e-ISSN

  • Volume of the periodical

    93

  • Issue of the periodical within the volume

    6

  • Country of publishing house

    CA - CANADA

  • Number of pages

    5

  • Pages from-to

    399-403

  • UT code for WoS article

    000355237100003

  • EID of the result in the Scopus database